Cardiac Amyloidosis: On the Road



In light of the coronavirus pandemic, we are taking a support, not distract approach and cancelling our spring programs. Read More

Register for upcoming webinars and view our extensive archives and portfolio of online education available for CME/CE credits.

South Florida  |  Houston  |  DC


South Florida Cardiac Amyloid Symposium
Wake up and Look Around
Towards Early Recognition, Diagnosis and Treatment of Cardiac Amyloidosis


Postponed until a later date

The Diplomat Beach Resort
3555 S Ocean Dr
Hollywood, FL 33019


4.5* CME credits available
*Credits subject to change

Agenda
Time Title Speaker
7:45 am  Breakfast and Registration
8:00 am  Welcome, Introduction and Knowledge Questions David Wolinsky, MD
8:05 am  Overview of Amyloidosis Charka Chaulagain, MD
8:45 am  Diagnosis of Cardiac Amyloid in 2020 Prem Soman, MD
9:25 am  Management Strategies David Wolinsky, MD
10:05 am  Break  
10:20 am  When All Else Fails- Advanced Heart Failure
 and Transplant– Part 1
Viviana Navas, MD
 
10:40 am  When All Else Fails- Advanced Heart Failure
 and Transplant– Part 2
Nicholas Brozzi, MD
11:00 am  Panel Discussion  
11:15 am
 Case Presentations
  • Amyloid and Aortic Stenosis
  • Amyloid and Systolic Failure
  • Thought it was Amyloid but Not Sure About the Tc-99m PYP Scan
 
Abdullah Sarkar, MD – Presenter
David Wolinsky, MD – Discussant
Diana Miranda, MD – Presenter
Viviana Navas, MD – Discussant
Prem Soman, MD
Noon
 Luncheon Panel
  • Amyloid Cases from the Nuclear  Lab 
  • Amyloid in South Florida: A Patient’s Perspective
David Wolinsky, MD – Moderator
Louis Wasserman, MD and
Karan Munuswamy, MD
Robert Lifton
1 pm  What the Future Holds and Closing Remarks David Wolinsky, MD


Cardiac Amyloidosis: From Missed and Undiagnosed, to Common and Treatable 

Postponed until a later date

Houston Methodist Hospital
6565 Fannin Street
Houston, TX 77030


 

Program Director: Mouaz Al-Mallah, MD, FASNC

3.25* CME credits available
4.5* ARRT Category A CE credits available for technologists 

*Credits subject to change
 
Agenda
Time Title Speaker
8:00am - 8:30am  Registration  
8:30am - 8:35am  Welcome Mouaz Al-Mallah, MD
8:35am - 9:00am  ATTR Cardiac Amyloidosis: Clinical Presentation and Outcomes Juan C. Lopez-Mattei, MD
9:00am - 9:20am  The Role of Echocardiography and Cardiac MRI in Suspected Cardiac Amyloidosis Faisal Nabi, MD
9:20am - 9:45am  PYP Imaging: Diagnostic Accuracy and Pitfalls John Mahmarian, MD
9:45am - 10:00am  Cardiac PET in Suspected Cardiac Amyloidosis Mouaz Al-Mallah, MD
10:00am - 10:20am  Management of ATTR Amyloidosis Barry Trachtenberg, MD
10:20am - 10:40am  Panel Discussion  
10:40am - 11:00am  Break  
11:00am - 11:45am
 Case Presentations
  1. Mohammad Chamsi Pasha, DO
  2. Ali Agha, MD
  3. Alpana Senapati, DO
Moderator:
Mouaz Al-Mallah, MD
 
Panel:
Faisal Nabi, MD
Mahwash Kassi, MD
John Mahmarian, MD
Barry Trachtenberg, MD
11:45am - Noon  Final Remarks Mouaz Al-Mallah, MD
 
This program is jointly sponsored by the American Society of Nuclear Cardiology and Houston Methodist.



Cardiac Amyloidosis: A Practical Primer


Postponed until a later date

The Ritz-Carlton, Tysons Corner
1700 Tysons Blvd, McLean VA 22102


4* CME credits available
*Credits subject to change


Agenda

Time Title Speaker
8:00 am Opening Remarks and Introduction James Udelson, MD
  Part I: The Basics  
8:05 am The Disease and the Work-up Prem Soman, MD, PhD
8:35 am The Imaging Sharmila Dorbala, MD, MPH
9:05 am The Treatment Frederick Ruberg, MD
9:35 am Q&A Panel
     
9:45 am Break  
  Part II: Imaging Nuts and Bolts  
10:00 am Practical Aspects of Acquiring and Interpreting Tc-99m PYP Imaging: An Interactive Workshop Prem Soman, MD, PhD, Joseph Dietz, CNMT, Panel
  Part III: Putting It All Together  
11:00 am Deconstructing Diagnosis and Management: A Case-Based Discussion Prem Soman, MD, PhD, James Udelson, MD and Panel
11:45 am Q&A Panel
Noon Closing Remarks Prem Soman, MD, PhD


The Cardiac Amyloidosis: On the Road programs will:
  • Address the knowledge, competence and performance gaps in disease epidemiology, pathophysiology, diagnosis and treatments for ATTR-CM. 
  • Improve diagnosis across all patient populations, timely referral to amyloid experts, and knowledge of treatment options with the goal of improving outcomes of patients with ATTR-CM. 
  • Enhance the understanding of the overlap of cardiac amyloidosis with other conditions leading to a misdiagnosis or delayed diagnosis.  
  • Focus on the diagnostic algorithm, including the appropriate use of Tc-99m PYP, and the importance of image interpretation alongside other clinical findings. 
  • Discuss the central role of Tc-99m PYP imaging and the protocols for acquisition, processing and interpretation to ensure understanding of the procedure and the data it provides.
     
Participants of these programs will be able to:
  • Describe amyloidosis, including specific types, cardiac features and disease burden.
  • Identify barriers to identification and diagnosis of patients suspected of ATTR.
  • Recognize patients at risk for hereditary ATTR (hATTR) and wild-type ATTR (wtATTR).
  • Summarize the diagnostic evaluation for cardiac amyloidosis including the differential diagnosis. 
  • Provide details of Tc-99m PYP including imaging protocol, semi-quantitative and quantitative scoring, interpretation including identifying false positive and false negative studies, and components of an appropriate report. 
  • Demonstrate understanding of current treatments for patients with ATTR-CM.

If you have any questions about registration, please contact info@asnc.org

These programs are supported by educational grants from Pfizer.
 

More Cardiac Amyloidosis Resources